FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385655551> ?p ?o ?g. }

• W4385655551 endingPage "4021" @default.
• W4385655551 startingPage "4021" @default.
• W4385655551 abstract "Background: The purpose of this study was to evaluate the clinical, biological and radiological responses to, and tolerability of, conventional transarterial chemoembolization (cTACE) using streptozocin for unresectable neuroendocrine liver metastases. Patients and Methods: A total of 52 patients with predominant liver disease were treated with cTACE using an emulsion of streptozocin, Lipiodol and embolization particles. A sequential approach was favored in patients with high liver tumor burden. Clinical, biological and radiological responses were evaluated using carcinoid symptoms, biomarkers and mRecist criteria, respectively. Results: A total of 127 procedures were performed with a sequential approach in 65% of patients. All patients received streptozocin and Lipiodol. Carcinoid syndrome was improved in 69% of patients after treatment (p = 0.01). Post-embolization syndrome was reported in 78% of patients. At the end of all cTACE, objective response and non-progressive disease were 32% and 70%, respectively. Progression-free survival was 18.3 ± 13.3 months (median 14.9) and median overall survival (OS) from start of treatment was 74 months. The OS at 1 year, 2 years, 3 years and 5 years was 91% (IC = 84–99%), 84% (CI = 72–95%), 69% (CI = 53–84%) and 63% (C = 46–81%), respectively. Conclusions: cTACE using streptozocin is an effective and well-tolerated palliative option for patients with neuroendocrine liver metastases, associated with prolonged survival and delayed time to progression." @default.
• W4385655551 created "2023-08-09" @default.
• W4385655551 creator A5007010881 @default.
• W4385655551 creator A5025791772 @default.
• W4385655551 creator A5043889844 @default.
• W4385655551 creator A5058588231 @default.
• W4385655551 creator A5063870522 @default.
• W4385655551 creator A5069022731 @default.
• W4385655551 date "2023-08-08" @default.
• W4385655551 modified "2023-10-18" @default.
• W4385655551 title "Conventional Transarterial Chemo embolization Using Streptozocin in Patients with Unresectable Neuroendocrine Liver Metastases" @default.
• W4385655551 cites W1532334298 @default.
• W4385655551 cites W1597026887 @default.
• W4385655551 cites W1968438974 @default.
• W4385655551 cites W1988370994 @default.
• W4385655551 cites W1990318166 @default.
• W4385655551 cites W1991443468 @default.
• W4385655551 cites W2000232900 @default.
• W4385655551 cites W2003860294 @default.
• W4385655551 cites W2014356332 @default.
• W4385655551 cites W2025662408 @default.
• W4385655551 cites W2031301095 @default.
• W4385655551 cites W2032215458 @default.
• W4385655551 cites W2035214608 @default.
• W4385655551 cites W2047757951 @default.
• W4385655551 cites W2052664954 @default.
• W4385655551 cites W2063661839 @default.
• W4385655551 cites W2080222082 @default.
• W4385655551 cites W2080299385 @default.
• W4385655551 cites W2117668987 @default.
• W4385655551 cites W2145255895 @default.
• W4385655551 cites W2156923932 @default.
• W4385655551 cites W2158604085 @default.
• W4385655551 cites W2211649965 @default.
• W4385655551 cites W2480881482 @default.
• W4385655551 cites W2494282649 @default.
• W4385655551 cites W2508639256 @default.
• W4385655551 cites W2522256404 @default.
• W4385655551 cites W2530769955 @default.
• W4385655551 cites W2567219319 @default.
• W4385655551 cites W2568398138 @default.
• W4385655551 cites W2725873592 @default.
• W4385655551 cites W2907788633 @default.
• W4385655551 cites W2913559246 @default.
• W4385655551 cites W2944065137 @default.
• W4385655551 cites W4233912527 @default.
• W4385655551 doi "https://doi.org/10.3390/cancers15164021" @default.
• W4385655551 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37627049" @default.
• W4385655551 hasPublicationYear "2023" @default.
• W4385655551 type Work @default.
• W4385655551 citedByCount "1" @default.
• W4385655551 crossrefType "journal-article" @default.
• W4385655551 hasAuthorship W4385655551A5007010881 @default.
• W4385655551 hasAuthorship W4385655551A5025791772 @default.
• W4385655551 hasAuthorship W4385655551A5043889844 @default.
• W4385655551 hasAuthorship W4385655551A5058588231 @default.
• W4385655551 hasAuthorship W4385655551A5063870522 @default.
• W4385655551 hasAuthorship W4385655551A5069022731 @default.
• W4385655551 hasBestOaLocation W43856555511 @default.
• W4385655551 hasConcept C126322002 @default.
• W4385655551 hasConcept C134018914 @default.
• W4385655551 hasConcept C141071460 @default.
• W4385655551 hasConcept C197934379 @default.
• W4385655551 hasConcept C2776035437 @default.
• W4385655551 hasConcept C2776297358 @default.
• W4385655551 hasConcept C2776694085 @default.
• W4385655551 hasConcept C2778019345 @default.
• W4385655551 hasConcept C2778375690 @default.
• W4385655551 hasConcept C2778448856 @default.
• W4385655551 hasConcept C2778822529 @default.
• W4385655551 hasConcept C2779066768 @default.
• W4385655551 hasConcept C2779280383 @default.
• W4385655551 hasConcept C2781151469 @default.
• W4385655551 hasConcept C2911120302 @default.
• W4385655551 hasConcept C555293320 @default.
• W4385655551 hasConcept C71924100 @default.
• W4385655551 hasConcept C90924648 @default.
• W4385655551 hasConceptScore W4385655551C126322002 @default.
• W4385655551 hasConceptScore W4385655551C134018914 @default.
• W4385655551 hasConceptScore W4385655551C141071460 @default.
• W4385655551 hasConceptScore W4385655551C197934379 @default.
• W4385655551 hasConceptScore W4385655551C2776035437 @default.
• W4385655551 hasConceptScore W4385655551C2776297358 @default.
• W4385655551 hasConceptScore W4385655551C2776694085 @default.
• W4385655551 hasConceptScore W4385655551C2778019345 @default.
• W4385655551 hasConceptScore W4385655551C2778375690 @default.
• W4385655551 hasConceptScore W4385655551C2778448856 @default.
• W4385655551 hasConceptScore W4385655551C2778822529 @default.
• W4385655551 hasConceptScore W4385655551C2779066768 @default.
• W4385655551 hasConceptScore W4385655551C2779280383 @default.
• W4385655551 hasConceptScore W4385655551C2781151469 @default.
• W4385655551 hasConceptScore W4385655551C2911120302 @default.
• W4385655551 hasConceptScore W4385655551C555293320 @default.
• W4385655551 hasConceptScore W4385655551C71924100 @default.
• W4385655551 hasConceptScore W4385655551C90924648 @default.
• W4385655551 hasIssue "16" @default.
• W4385655551 hasLocation W43856555511 @default.
• W4385655551 hasLocation W43856555512 @default.

• next